Finance
why Spruce Biosciences Inc [SPRB] is a Good Choice for Investors After New Price Target of $4.20
Spruce Biosciences Inc [NASDAQ: SPRB] slipped around -4.38 points on Thursday, while shares priced at $0.81 at the close of the session, down -84.38%. The company report on March 13, 2024 at 4:08 PM that Spruce Biosciences Reports Full Year 2023 Financial Results and Provides
